{"created":"2023-07-25T10:23:19.636338+00:00","id":2951,"links":{},"metadata":{"_buckets":{"deposit":"8444b777-0f0f-4f99-a299-8188e09de113"},"_deposit":{"created_by":15,"id":"2951","owners":[15],"pid":{"revision_id":0,"type":"depid","value":"2951"},"status":"published"},"_oai":{"id":"oai:air.repo.nii.ac.jp:00002951","sets":["611:968:969:1091"]},"author_link":["10668"],"item_10006_alternative_title_32":{"attribute_name":"別タイトル","attribute_value_mlt":[{"subitem_alternative_title":"SLE患者のPBMCの中にはmiR-155,miR-17,and miR-181bの発現が低下しており,activation-induced cytidine deaminase と interferon-αの発現が亢進している"}]},"item_10006_biblio_info_34":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2017-03-22","bibliographicIssueDateType":"Issued"},"bibliographic_titles":[{}]}]},"item_10006_date_granted_41":{"attribute_name":"学位授与年月日","attribute_value_mlt":[{"subitem_dategranted":"2017-03-22"}]},"item_10006_degree_grantor_40":{"attribute_name":"学位授与機関","attribute_value_mlt":[{"subitem_degreegrantor":[{"subitem_degreegrantor_name":"秋田大学"}]}]},"item_10006_degree_name_39":{"attribute_name":"学位名","attribute_value_mlt":[{"subitem_degreename":"博士(医学)"}]},"item_10006_dissertation_number_42":{"attribute_name":"学位授与番号","attribute_value_mlt":[{"subitem_dissertationnumber":"11401甲第1200号"}]},"item_10006_publisher_28":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"秋田大学"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"加賀, 一"}],"nameIdentifiers":[{"nameIdentifier":"10668","nameIdentifierScheme":"WEKO"}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2017-06-22"}],"displaytype":"detail","filename":"ihakuko1200.pdf","filesize":[{"value":"394.6 kB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"内容要旨及び審査結果要旨","url":"https://air.repo.nii.ac.jp/record/2951/files/ihakuko1200.pdf"},"version_id":"568f921f-89ce-43f4-af39-944be66bb3cb"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"thesis","resourceuri":"http://purl.org/coar/resource_type/c_46ec"}]},"item_title":"Downregulated expression of miR-155,miR-17,and miR-181b,and upregulated expression of activation-induced cytidine deaminase and interferon-α in PBMCs from patients with SLE","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"Downregulated expression of miR-155,miR-17,and miR-181b,and upregulated expression of activation-induced cytidine deaminase and interferon-α in PBMCs from patients with SLE"}]},"item_type_id":"10006","owner":"15","path":["1091"],"pubdate":{"attribute_name":"公開日","attribute_value":"2017-06-22"},"publish_date":"2017-06-22","publish_status":"0","recid":"2951","relation_version_is_last":true,"title":["Downregulated expression of miR-155,miR-17,and miR-181b,and upregulated expression of activation-induced cytidine deaminase and interferon-α in PBMCs from patients with SLE"],"weko_creator_id":"15","weko_shared_id":-1},"updated":"2023-07-25T11:29:50.989201+00:00"}